Intelligent Bio Solutions Inc. (NASDAQ:INBS) Short Interest Update

Intelligent Bio Solutions Inc. (NASDAQ:INBS) was the recipient of a significant increase in short interest in the month of February. As of February 28th, there was short interest totalling 454,100 shares, an increase of 17.3% from the February 13th total of 387,100 shares. Currently, 6.8% of the shares of the company are sold short. Based on an average daily volume of 200,500 shares, the days-to-cover ratio is currently 2.3 days.

Intelligent Bio Solutions Stock Performance

Intelligent Bio Solutions stock traded up $0.05 during mid-day trading on Wednesday, reaching $2.17. The company’s stock had a trading volume of 126,023 shares, compared to its average volume of 541,171. The business has a 50 day moving average price of $1.92 and a 200-day moving average price of $1.70. Intelligent Bio Solutions has a twelve month low of $1.00 and a twelve month high of $4.64.

Intelligent Bio Solutions (NASDAQ:INBS) last posted its earnings results on Thursday, February 13th. The company reported ($0.50) earnings per share (EPS) for the quarter. The company had revenue of $610 billion during the quarter. Intelligent Bio Solutions had a negative net margin of 323.79% and a negative return on equity of 146.03%. Research analysts expect that Intelligent Bio Solutions will post -1.25 earnings per share for the current year.

Intelligent Bio Solutions Company Profile

Intelligent Bio Solutions Inc, a medical technology company, developing non-invasive, real-time monitoring, and diagnostic tests for patients and their primary health practitioners. It offers saliva glucose biosensor for diabetes management that measures glucose in saliva. The company also provides intelligent fingerprinting drug screening system, a revolutionizing portable testing through fingerprint sweat analysis, which has the potential for broader applications in additional fields; and biosensor platform for biochemistry, immunology, tumor markers, hormones, and nucleic acid diagnostic modalities.